Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats

Toxicology in Vitro

Volumn 28, Issue 4, 2014, Pages 479-484

  Bellaver, Bruna ^a   Souza, Débora Guerini ^a   Souza, Diogo Onofre ^a   Quincozes Santos, André ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Aging; Cytokines; Glutathione; Hippocampal astrocytes; Resveratrol

Indexed keywords

ANTIOXIDANT; CYTOKINE; RESVERATROL; STILBENE DERIVATIVE;

AGING; ANIMAL; ASTROCYTE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; HIPPOCAMPUS; METABOLISM; NEWBORN; PHYSIOLOGY; RAT; WISTAR RAT;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; ASTROCYTES; CELLS, CULTURED; CYTOKINES; HIPPOCAMPUS; RATS; RATS, WISTAR; STILBENES;

EID: 84893666666     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.01.006     Document Type: Article

References (58)

1. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
2. Arredondo F., Echeverry C., Abin-Carriquiry J.A., Blasina F., Antunez K., Jones D.P., Go Y.M., Liang Y.L., Dajas F. After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. Free Radic. Biol. Med. 2010, 49:738-747.
3. Banerjee R., Vitvitsky V., Garg S.K. The undertow of sulfur metabolism on glutamatergic neurotransmission. Trends Biochem. Sci. 2008, 33:413-419.
4. Bastianetto S., Quirion R. Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp. Neurol. 2010, 225:237-239.
5. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
6. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
7. Belanger M., Allaman I., Magistretti P.J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011, 14:724-738.
8. Bobermin L.D., Quincozes-Santos A., Guerra M.C., Leite M.C., Souza D.O., Goncalves C.A., Gottfried C. Resveratrol prevents ammonia toxicity in astroglial cells. PLoS One 2012, 7:e52164.
9. Calabrese V., Cornelius C., Mancuso C., Pennisi G., Calafato S., Bellia F., Bates T.E., Giuffrida Stella A.M., Schapira T., Dinkova Kostova A.T., Rizzarelli E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem. Res. 2008, 33:2444-2471.
10. Calkins M.J., Johnson D.A., Townsend J.A., Vargas M.R., Dowell J.A., Williamson T.P., Kraft A.D., Lee J.M., Li J., Johnson J.A. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signal. 2009, 11:497-508.
11. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
12. de Almeida L.M., Pineiro C.C., Leite M.C., Brolese G., Tramontina F., Feoli A.M., Gottfried C., Goncalves C.A. Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures. Cell. Mol. Neurobiol. 2007, 27:661-668.
13. Delmas D., Jannin B., Latruffe N. Resveratrol: preventing properties against vascular alterations and ageing. Mol. Nutr. Food Res. 2005, 49:377-395.
14. Diamond M.C., Johnson R.E., Ingham C.A. Morphological changes in the young, adult and aging rate cerebral cortex, hippocampus, and diencephalon. Behav. Biol. 1975, 14:163-174.
15. dos Santos A.Q., Nardin P., Funchal C., de Almeida L.M., Jacques-Silva M.C., Wofchuk S.T., Goncalves C.A., Gottfried C. Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch. Biochem. Biophys. 2006, 453:161-167.
16. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 2000, 62:649-671.
17. Erlank H., Elmann A., Kohen R., Kanner J. Polyphenols activate Nrf2 in astrocytes via H2O2, semiquinones, and quinones. Free Radic. Biol. Med. 2011, 51:2319-2327.
18. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18:685-716.
19. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 2006, 97:1634-1658.
20. Hertz L., Peng L., Lai J.C. Functional studies in cultured astrocytes. Methods 1998, 16:293-310.
21. Hertz L., Zielke H.R. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 2004, 27:735-743.
22. Huang T.C., Lu K.T., Wo Y.Y., Wu Y.J., Yang Y.L. Resveratrol protects rats from Abeta-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS One 2011, 6:e29102.
23. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
24. Khan M.M., Ahmad A., Ishrat T., Khan M.B., Hoda M.N., Khuwaja G., Raza S.S., Khan A., Javed H., Vaibhav K., Islam F. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res. 2010, 1328:139-151.
25. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
26. Kode A., Rajendrasozhan S., Caito S., Yang S.R., Megson I.L., Rahman I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L478-L488.
27. Lange S.C., Bak L.K., Waagepetersen H.S., Schousboe A., Norenberg M.D. Primary cultures of astrocytes: their value in understanding astrocytes in health and disease. Neurochem. Res. 2012, 37:2569-2588.
28. Lee M., Cho T., Jantaratnotai N., Wang Y.T., McGeer E., McGeer P.L. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J. 2010, 24:2533-2545.
29. Lewis D.K., Thomas K.T., Selvamani A., Sohrabji F. Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function. Neurobiol. Aging 2012, 33(1123). e1121-e1116.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
31. Maragakis N.J., Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2006, 2:679-689.
32. Nedergaard M., Ransom B., Goldman S.A. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003, 26:523-530.
33. Parpura V., Heneka M.T., Montana V., Oliet S.H., Schousboe A., Haydon P.G., Stout R.F., Spray D.C., Reichenbach A., Pannicke T., Pekny M., Pekna M., Zorec R., Verkhratsky A. Glial cells in (patho)physiology. J. Neurochem. 2012, 121:4-27.
34. Pertusa M., Garcia-Matas S., Rodriguez-Farre E., Sanfeliu C., Cristofol R. Astrocytes aged in vitro show a decreased neuroprotective capacity. J. Neurochem. 2007, 101:794-805.
35. Pope S.A., Milton R., Heales S.J. Astrocytes protect against copper-catalysed loss of extracellular glutathione. Neurochem. Res. 2008, 33:1410-1418.
36. Quincozes-Santos A., Andreazza A.C., Goncalves C.A., Gottfried C. Actions of redox-active compound resveratrol under hydrogen peroxide insult in C6 astroglial cells. Toxicol. In Vitro 2010, 24:916-920.
37. Quincozes-Santos A., Andreazza A.C., Nardin P., Funchal C., Goncalves C.A., Gottfried C. Resveratrol attenuates oxidative-induced DNA damage in C6 glioma cells. Neurotoxicology 2007, 28:886-891.
38. Quincozes-Santos A., Bobermin L.D., Latini A., Wajner M., Souza D.O., Goncalves C.A., Gottfried C. Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1. PLoS One 2013, 8:e64372.
39. Quincozes-Santos A., Gottfried C. Resveratrol modulates astroglial functions: neuroprotective hypothesis. Ann. NY Acad. Sci. 2011, 1215:72-78.
40. Quincozes-Santos A., Nardin P., de Souza D.F., Gelain D.P., Moreira J.C., Latini A., Goncalves C.A., Gottfried C. The janus face of resveratrol in astroglial cells. Neurotox. Res. 2009, 16:30-41.
41. Ransom B.R., Ransom C.B. Astrocytes: multitalented stars of the central nervous system. Methods Mol. Biol. 2012, 814:3-7.
42. Richard T., Pawlus A.D., Iglesias M.L., Pedrot E., Waffo-Teguo P., Merillon J.M., Monti J.P. Neuroprotective properties of resveratrol and derivatives. Ann. NY Acad. Sci. 2011, 1215:103-108.
43. Sakata Y., Zhuang H., Kwansa H., Koehler R.C., Dore S. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp. Neurol. 2010, 224:325-329.
44. Santello M., Bezzi P., Volterra A. TNFalpha controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 2011, 69:988-1001.
45. Santello M., Volterra A. TNFalpha in synaptic function: switching gears. Trends Neurosci. 2012, 35:638-647.
46. Segovia G., Del Arco A., Prieto L., Mora F. Glutamate-glutamine cycle and aging in striatum of the awake rat: effects of a glutamate transporter blocker. Neurochem. Res. 2001, 26:37-41.
47. Segovia G., Porras A., Del Arco A., Mora F. Glutamatergic neurotransmission in aging: a critical perspective. Mech. Ageing Dev. 2001, 122:1-29.
48. Skytt D.M., Madsen K.K., Pajecka K., Schousboe A., Waagepetersen H.S. Characterization of primary and secondary cultures of astrocytes prepared from mouse cerebral cortex. Neurochem. Res. 2010, 35:2043-2052.
49. Souza D.G., Bellaver B., Souza D.O., Quincozes-Santos A. Characterization of adult rat astrocyte cultures. PLoS One 2013, 8:e60282.
50. Sun W., McConnell E., Pare J.F., Xu Q., Chen M., Peng W., Lovatt D., Han X., Smith Y., Nedergaard M. Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. Science 2013, 339:197-200.
51. Tanabe K., Matsushima-Nishiwaki R., Yamaguchi S., Iida H., Dohi S., Kozawa O. Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells. J. Neuroinflammation 2010, 7:16.
52. Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?. Trends Pharmacol. Sci. 1998, 19:328-334.
53. Tuttolomondo A., Di Raimondo D., di Sciacca R., Pinto A., Licata G. Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 2008, 14:3574-3589.
54. Vingtdeux V., Dreses-Werringloer U., Zhao H., Davies P., Marambaud P. Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neurosci. 2008, 9(Suppl 2):S6.
55. Volterra A., Trotti D., Floridi S., Racagni G. Reactive oxygen species inhibit high-affinity glutamate uptake: molecular mechanism and neuropathological implications. Ann. NY Acad. Sci. 1994, 738:153-162.
56. Volterra A., Trotti D., Tromba C., Floridi S., Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 1994, 14:2924-2932.
57. Wang D.D., Bordey A. The astrocyte odyssey. Prog. Neurobiol. 2008, 86:342-367.
58. Wu Z., Xu Q., Zhang L., Kong D., Ma R., Wang L. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem. Res. 2009, 34:1393-1400.